☰
Karyopharm Therapeutics, a renowned pharmaceutical firm focused on the development, discovery, and commercialization of new therapies to treat cancer and other major diseases, reportedly announced that four posters pertaining to XPOVIO®....
The data was presented at the annual meeting of American Epilepsy Society (AES) held in Baltimore Stokes will apply for investigational new drug (IND) to the U.S. FDA in the first half of 2020 Massachusetts headquartered Stoke ....
The reward will accelerate the development of VE707 for various multi-drug resistant infections Vedanta Biosciences is eligible for an additional $3.5 million subject to certain milestones Vedanta Biosciences, a pre-clinical st....
Huawei and ZTE were first claimed to be potential national security threats by a U.S Congressional panel in 2012. Huawei Technologies Co., Ltd., a Chinese multinational technology firm, has reportedly sued the U.S. Federal Communica....
Atomwise Inc., a U.S.-based AI system developer has recently formed a joint venture (JV) with biotech company, StemoniX Inc. to merge its AI technology with StemoniX's human microOrgan® platform. Sources close the move suggest that ....
FDA grants approval for Genentech’s Tecentriq – Chemotherapy combination treatment, based on positive results from Phase III Impower130 trial The combination is designed to be used as a first-line treatment for metast....
Panasonic announced the sale of its of semiconductor business to Taiwan based Nuvoton The Panasonic-TowerJazz JV comprises three manufacturing units operated in Japan Israel headquartered chip manufacturer- TowerJazz a....
Various instances of cyberattacks, viruses, and other malicious threats across the healthcare sector have raised many eyebrows owing to the security of confidential patient information. In order to tackle with these attacks, Canon Medical S....
It will be the first mini-robotic warehouse of Ocado in Bristol. Ocado, a British online grocer, has announced that it has been planning to open a mini robotic warehouse by 2021 to expand its customer base in the U.K. The revelation indic....
This would be the first registered immune checkpoint inhibitor for treating PD-L1-positive TNBC in Japan. The drug has also been listed on NHI reimbursement price list. Chugai Pharmaceutical Co. Ltd., a Japanese drug manufactur....
